Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Cytopenia 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 16fludarabine phosphate 12fludarabine 11Tacrolimus 11Whole-Body Irradiation 10Mycophenolic Acid 9Melphalan 9Busulfan 9Peripheral Blood Stem Cell Transplantation 7Alemtuzumab 7Methotrexate 5Cyclosporine 5Stem Cell Transplantation 4thymoglobulin 2sargramostim 2Hematopoietic Stem Cell Transplantation 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Antilymphocyte Serum 2visilizumab 1nicotinamide-beta-riboside 1methanesulfonic acid 1merphos 1X-Rays 1Transplantation 1Thiotepa 1Teriparatide 1Specimen Handling 1Sirolimus 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anemia, Aplastic × Emapalumab × Clear all
NCT06430788 2025-12-17

A Study of Emapalumab for Pediatric Aplastic Anemia

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
35 enrolled
Classical hematology

Bone Marrow Failure Disorders, Cytopenia, Anemia, Aplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡